Literature DB >> 23178353

Breast cancer survivors with lymphedema: glimpses of their daily lives.

Sheila H Ridner1, Vaughn Sinclair, Jie Deng, Candace M Bonner, Nancy Kidd, Mary S Dietrich.   

Abstract

Breast cancer survivors with lymphedema experience physical, psychosocial, and quality-of-life difficulties. Cancer treatment-related lymphedema often is viewed as a disabling condition, and that assumption has fostered an environment in which oncology nurses are not actively involved in the care of patients with lymphedema. Little is known about how breast cancer survivors with lymphedema structure their daily lives. This article describes an effort to determine whether lymphedema truly is a disabling condition by collecting symptom data and self-generated narratives from breast cancer survivors with lymphedema regarding their eating habits, daily activities, substance use, and future plans. Although the sample experienced multiple symptoms, lymphedema duration and degree of extracellular arm fluid did not appear to influence those symptoms. In addition, participants led full, rich, busy lives. The findings do not support the notion that patients with lymphedema live as disabled people. A disability model may not be optimal to guide research design or patient care; rather, a symptom management model better explains the findings and implies that active involvement by nurses in lymphedema patient care and education is indicated.

Entities:  

Mesh:

Year:  2012        PMID: 23178353     DOI: 10.1188/12.CJON.609-614

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  7 in total

1.  Factors predicting adherence to risk management behaviors of women at increased risk for developing lymphedema.

Authors:  Kerry A Sherman; Suzanne M Miller; Pagona Roussi; Alan Taylor
Journal:  Support Care Cancer       Date:  2014-06-27       Impact factor: 3.603

2.  Breast cancer morbidity: questionnaire survey of patients on the long term effects of disease and adjuvant therapy.

Authors:  Stefan Feiten; Jan Dünnebacke; Jochen Heymanns; Hubert Köppler; Jörg Thomalla; Christoph van Roye; Diana Wey; Rudolf Weide
Journal:  Dtsch Arztebl Int       Date:  2014-08-04       Impact factor: 5.594

3.  Development and validation of the Lymphedema Symptom and Intensity Survey-Arm.

Authors:  Sheila H Ridner; Mary S Dietrich
Journal:  Support Care Cancer       Date:  2015-03-10       Impact factor: 3.603

4.  A randomized controlled trial of expressive writing in breast cancer survivors with lymphedema.

Authors:  Stephanie J Sohl; Mary S Dietrich; Kenneth A Wallston; Sheila H Ridner
Journal:  Psychol Health       Date:  2017-03-30

5.  Breast cancer survivors' perspectives of critical lymphedema self-care support needs.

Authors:  Sheila H Ridner; Bethany A Rhoten; M Elise Radina; Melissa Adair; Sydney Bush-Foster; Vaughn Sinclair
Journal:  Support Care Cancer       Date:  2016-01-26       Impact factor: 3.603

6.  Magnetic resonance imaging and bioimpedance evaluation of lymphatic abnormalities in patients with breast cancer treatment-related lymphedema.

Authors:  Paula M C Donahue; Rachelle Crescenzi; Chelsea Lee; Maria Garza; Niral J Patel; Kalen J Petersen; Manus J Donahue
Journal:  Breast Cancer Res Treat       Date:  2020-06-29       Impact factor: 4.872

Review 7.  Breast and gynecologic cancer-related extremity lymphedema: a review of diagnostic modalities and management options.

Authors:  Pankaj Tiwari; Michelle Coriddi; Ritu Salani; Stephen P Povoski
Journal:  World J Surg Oncol       Date:  2013-09-22       Impact factor: 2.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.